Synapticure is reinforcing its position in neurology-focused telehealth by spotlighting its role in Parkinson’s and movement-disorder care. The company announced that its Movement Disorders Director, Dr. Elizabeth Ferluga, will speak at an APDA Georgia Chapter educational workshop on March 13 in Sandy Springs, Georgia, alongside Emory School of Medicine’s Dr. Cristina Pritchett.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The session will focus on how telehealth can expand access to expert neurological care, mental health support, and wellness resources for people living with Parkinson’s disease. Synapticure is emphasizing a holistic model that addresses both physical symptoms and emotional well-being, including between-appointment support to enhance patient engagement.
Across its messaging, Synapticure highlights a care approach that extends beyond episodic visits, which may improve patient retention and support recurring revenue from virtual services. The company’s focus on continuous access, confidence-building, and mental health aligns with broader digital health trends favoring integrated, patient-centric care models.
Participation in the APDA Georgia event also underscores Synapticure’s strategy of building relationships with nonprofit organizations and academic partners such as Emory. These collaborations can bolster clinical credibility, facilitate outcomes-based data generation, and potentially strengthen the company’s position in future reimbursement discussions for remote Parkinson’s and mental health services.
By positioning its clinical leadership as visible thought leaders in the Parkinson’s community, Synapticure is working to deepen its presence in the movement-disorder ecosystem. While no new financial or product-specific details were disclosed, the company’s activities this week point to a deliberate growth strategy centered on scalable virtual neurology care.
If Synapticure can effectively translate educational outreach into referral networks or formal partnerships, it may support long-term demand for its telehealth offerings. Overall, the week marked a strategically positive period for Synapticure, with increased visibility and reinforced branding as a telehealth leader in Parkinson’s and movement-disorder care.